New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.

Scientists have developed a new artificial intelligence–powered blood test that may be able to detect early signs of serious ...

Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...

A study led by scientists at NYU Langone Health and its Perlmutter Cancer Center has shown that monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer ...

PORTLAND, Ore. — Near the elevators of Oregon Health and Science University's Knight Cancer Research Building, you won't find Doritos or Coca-Cola inside the vending machines. You'll find DNA kits ...

Liver disease is a growing health problem around the world, yet many people who develop it do not know they are sick until the disease has already become serious. Conditions such as liver fibrosis and ...